Moderna's (MRNA) COVID-19 Vaccine Gets FDA Panel's Backing

Moderna, Inc. MRNA announced that the FDA's Vaccines and Related Biological Products Advisory Committee has voted in favor of FDA granting an emergency use authorization (EUA) to its mRNA-based coronavirus vaccine candidate, mRNA-1273.

from Google Alert - Business https://ift.tt/2KirNwS
Moderna, Inc. MRNA announced that the FDA's Vaccines and Related Biological Products Advisory Committee has voted in favor of FDA granting an emergency use authorization (EUA) to its mRNA-based coronavirus vaccine candidate, mRNA-1273. https://ift.tt/eA8V8J

Comments

Popular posts from this blog

Jobless Rate Drops

Electrolytic Fixed Power Capacitors Market Competitive intelligence & regional outlook 2020

USU project among finalists for $3 million solar energy tech prize